In the pharmaceutical industry, ultra-fine grinding is a key process, and its necessity focuses on three aspects: First, it refines raw materials to the micron level, increases the specific surface area, significantly improves the dissolution rate and bioavailability of insoluble components, reduces dosage, and lowers toxic and side effects; Second, it achieves uniform mixing and full cell wall breaking of compound drugs or precious medicinal materials, avoids component segregation, ensures accurate preparation content, and meets the “content uniformity” standard; Third, it optimizes powder fluidity and particle size distribution, adapts to the production of multiple dosage forms such as tablets and capsules, reduces process problems, improves production stability, and also supports the research and development of new formulations such as targeted and immediate-release preparations.
